Interestingly, these immature PF-NK cells are characterized by a strong downregulation of the main activating NK cell receptors (primarily NKp30 and DNAM-1) that may be a consequence of their engagement by specific ligands expressed on tumor cell surface or present in soluble form together with immunomodulatory soluble factors in the PF. The gene discussed is CD226; the disease is neoplasm.